Ries M - Search Results

1

Disease manifestations and X inactivation in heterozygous females with Fabry disease.

Maier EM, Osterrieder S, Whybra C, Ries M, Gal A, Beck M, Roscher AA, Muntau AC. Maier EM, et al. Among authors: ries m. Acta Paediatr Suppl. 2006 Apr;95(451):30-8. doi: 10.1080/08035320600618809. Acta Paediatr Suppl. 2006. PMID: 16720462

2

Cardiac manifestations of Anderson-Fabry disease in heterozygous females.

Kampmann C, Baehner F, Whybra C, Martin C, Wiethoff CM, Ries M, Gal A, Beck M. Kampmann C, et al. Among authors: ries m. J Am Coll Cardiol. 2002 Nov 6;40(9):1668-74. doi: 10.1016/s0735-1097(02)02380-x. J Am Coll Cardiol. 2002. PMID: 12427421 Free article.

3

Thirty-four novel mutations of the GLA gene in 121 patients with Fabry disease.

Schäfer E, Baron K, Widmer U, Deegan P, Neumann HP, Sunder-Plassmann G, Johansson JO, Whybra C, Ries M, Pastores GM, Mehta A, Beck M, Gal A. Schäfer E, et al. Among authors: ries m. Hum Mutat. 2005 Apr;25(4):412. doi: 10.1002/humu.9327. Hum Mutat. 2005. PMID: 15776423

4

The early clinical phenotype of Fabry disease: a study on 35 European children and adolescents.

Ries M, Ramaswami U, Parini R, Lindblad B, Whybra C, Willers I, Gal A, Beck M. Ries M, et al. Eur J Pediatr. 2003 Nov;162(11):767-72. doi: 10.1007/s00431-003-1299-3. Epub 2003 Sep 20. Eur J Pediatr. 2003. PMID: 14505049

5

Neurological manifestation of Fabry disease in females.

Wendrich K, Whybra C, Ries M, Gal A, Beck M. Wendrich K, et al. Among authors: ries m. Contrib Nephrol. 2001;(136):241-4. doi: 10.1159/000060195. Contrib Nephrol. 2001. PMID: 11688387 No abstract available.

6

Clinical manifestation in female Fabry disease patients.

Whybra C, Wendrich K, Ries M, Gal A, Beck M. Whybra C, et al. Among authors: ries m. Contrib Nephrol. 2001;(136):245-50. doi: 10.1159/000060196. Contrib Nephrol. 2001. PMID: 11688388 No abstract available.

7

Anderson-Fabry disease in children and adolescents.

Beck M, Whybra C, Wendrich K, Gal A, Ries M. Beck M, et al. Among authors: ries m. Contrib Nephrol. 2001;(136):251-5. doi: 10.1159/000060197. Contrib Nephrol. 2001. PMID: 11688389 No abstract available.

8

Angiokeratoma and pain, but not Fabry's disease: considerations for differential diagnosis.

Ries M, Wendrich K, Whybra C, Kampmann C, Gal A, Beck M. Ries M, et al. Contrib Nephrol. 2001;(136):256-9. doi: 10.1159/000060198. Contrib Nephrol. 2001. PMID: 11688390 No abstract available.

9

The Mainz Severity Score Index: a new instrument for quantifying the Anderson-Fabry disease phenotype, and the response of patients to enzyme replacement therapy.

Whybra C, Kampmann C, Krummenauer F, Ries M, Mengel E, Miebach E, Baehner F, Kim K, Bajbouj M, Schwarting A, Gal A, Beck M. Whybra C, et al. Among authors: ries m. Clin Genet. 2004 Apr;65(4):299-307. doi: 10.1111/j.1399-0004.2004.00219.x. Clin Genet. 2004. PMID: 15025723

10

Enzyme-replacement therapy with agalsidase alfa in children with Fabry disease.

Ries M, Clarke JT, Whybra C, Timmons M, Robinson C, Schlaggar BL, Pastores G, Lien YH, Kampmann C, Brady RO, Beck M, Schiffmann R. Ries M, et al. Pediatrics. 2006 Sep;118(3):924-32. doi: 10.1542/peds.2005-2895. Pediatrics. 2006. PMID: 16950982 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

653 results

Search Page

Filters